MedTrace Logo

Efficacy of RPh201 Applied Topically for the Treatment of Hard to Heal Chronic Ulcerated Wounds

NCT01429519 · Status: TERMINATED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 4

Last updated 2018-09-04

No results posted yet for this study

Summary

The study objectives are to evaluate safety and efficacy of topical administration of RPh201 oil solution (botanical extract) for treatment of patients with hard to heal chronic ulcerated wounds.

Conditions

  • Chronic Wound

Interventions

DRUG

RPh201, botanical drug product

topical, three times per week for a period of 4 consecutive weeks, followed by a single follow up visit 3 months post end of the last treatment day

Sponsors & Collaborators

  • TransCom Global Ltd. (CRO)

    collaborator UNKNOWN

  • Regenera Pharma Ltd

    lead INDUSTRY

Principal Investigators

  • Eran Tamir, Dr. · High Risk Foot Clinic - Maccabi Health Services Tel Aviv

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-12-31
Primary Completion
2012-12-31
Completion
2012-12-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01429519 on ClinicalTrials.gov